No One Should Die Waiting for an Organ Transplant. These Doctors Want to Ensure That Doesn’t Happen
By Tanya Lewis,
Scientific American
| 10. 18. 2023
Robert Montgomery walked deliberately down the hospital hallway carrying a stainless-steel bowl containing a living human kidney resting on a bed of ice. Minutes earlier the organ had been in one man's body. It was about to be implanted into another man to keep him alive.
It was about 11 A.M. on a Monday this past spring. I followed Montgomery, an abdominal transplant surgeon and director of the NYU Langone Transplant Institute, into an operating room where 49-year-old John Primavera was waiting to receive the precious kidney. Monitors beeped; Shakira played on the sound system. Montgomery, who has performed thousands of transplants, walked up to the operating table and gently lowered the organ into Primavera's abdomen. The kidney, offered to Primavera by his close friend Thomas Kenny, was pale and about the size and shape of a mango. Montgomery motioned for me to step toward the table. I watched as he removed the clamps on the artery he had just sewn onto the replacement organ. The kidney flushed pink with blood and began to pulse with life.
This kidney transplant...
Related Articles
By Maggie Astor, The New York Times | 06.23.2026
Every year, patients undergo millions of in vitro fertilization procedures worldwide. Only a minority result in a live birth.
In an effort to improve the odds, scientists have developed an array of “add-ons” that could in theory identify the most...
By Carl Zimmer and Catrin Einhorn, The New York Times | 06.25.2026
The Trump administration and a company that is promising to bring long-gone animals back from extinction announced a partnership on Thursday to preserve cells, tissue and DNA from threatened and endangered species.
The company, Colossal Biosciences, said its goal was...
By Marisa Flook , BioNews | 06.29.2026
An anti-ageing gene therapy not approved by the US Food and Drug Administration (FDA) is set to be offered by an American company at overseas clinics outside of US jurisdiction.
The treatment, developed by Minicircle from Austin, Texas, uses a...
By Philip Ball , Nature | 06.17.2026
Our genomes are full of mutations that have the potential to damage our health or even kill us. Yet most of them rarely cause problems. Why? It’s partly thanks to a family of proteins that mask, or ‘buffer’, the ill...